Use of transplatin to prevent hearing loss
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 2, 2016
Grant Date -
Mar 27, 2014
app pub date -
Dec 3, 2013
filing date -
Jul 15, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods and compositions for treating and preventing toxic side effects of platinum-based chemotherapy agents are disclosed, in which transplatin is administered to a subject. Transplatin is shown to have protective effects against cisplatin-induced ototoxicity, nephotoxicity and neurotoxicity. Anti-inflammatory activity of transplatin is demonstrated and methods and compositions for treating and preventing inflammatory pain are described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully